Poxel S.A. (POXEL.PA)
EUR 0.45
(4.55%)
EUR 0.45
(4.55%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.91 EUR | 15.74% |
| 2022 | -1.08 EUR | -30.12% |
| 2021 | -0.83 EUR | 28.45% |
| 2020 | -1.16 EUR | -17.17% |
| 2019 | -0.99 EUR | -283.33% |
| 2018 | 0.54 EUR | 154.55% |
| 2017 | -0.99 EUR | 14.66% |
| 2016 | -1.16 EUR | -70.59% |
| 2015 | -0.68 EUR | 15.0% |
| 2014 | -0.80 EUR | 31.03% |
| 2013 | -1.16 EUR | -61.11% |
| 2012 | -0.72 EUR | 16.28% |
| 2011 | -0.86 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 FY | - EUR | 100.0% |
| 2023 Q4 | -0.28 EUR | 0.0% |
| 2023 Q2 | -0.83 EUR | 0.0% |
| 2022 FY | - EUR | -30.12% |
| 2022 Q4 | -0.62 EUR | 0.0% |
| 2022 Q2 | -0.46 EUR | 0.0% |
| 2021 FY | - EUR | 28.45% |
| 2021 Q2 | -0.28 EUR | 0.0% |
| 2021 Q4 | -0.55 EUR | 0.0% |
| 2020 Q2 | -0.45 EUR | 0.0% |
| 2020 FY | - EUR | -17.17% |
| 2020 Q4 | -0.70 EUR | 0.0% |
| 2019 FY | - EUR | -283.33% |
| 2019 Q1 | -0.25 EUR | -4.17% |
| 2019 Q2 | -0.22 EUR | 12.0% |
| 2019 Q4 | -0.77 EUR | 0.0% |
| 2018 FY | - EUR | 154.55% |
| 2018 Q4 | -0.24 EUR | 0.0% |
| 2018 Q1 | 0.14 EUR | 125.45% |
| 2018 Q2 | 0.28 EUR | 100.0% |
| 2017 Q2 | -0.42 EUR | -75.0% |
| 2017 FY | - EUR | 14.66% |
| 2017 Q4 | -0.55 EUR | 0.0% |
| 2017 Q1 | -0.24 EUR | 55.56% |
| 2016 Q1 | -0.30 EUR | 18.92% |
| 2016 Q4 | -0.54 EUR | 0.0% |
| 2016 FY | - EUR | -70.59% |
| 2016 Q2 | -0.63 EUR | -110.0% |
| 2015 Q2 | -0.31 EUR | -72.22% |
| 2015 FY | - EUR | 15.0% |
| 2015 Q4 | -0.37 EUR | -105.56% |
| 2015 Q3 | -0.18 EUR | 41.94% |
| 2015 Q1 | -0.18 EUR | 35.71% |
| 2014 Q4 | -0.28 EUR | 22.22% |
| 2014 Q3 | -0.36 EUR | 73.33% |
| 2014 Q2 | -1.35 EUR | -275.0% |
| 2014 Q1 | -0.36 EUR | 83.56% |
| 2014 FY | - EUR | 31.03% |
| 2013 FY | - EUR | -61.11% |
| 2013 Q4 | -2.19 EUR | -655.17% |
| 2013 Q2 | -0.43 EUR | -48.28% |
| 2013 Q3 | -0.29 EUR | 32.56% |
| 2013 Q1 | -0.29 EUR | 0.0% |
| 2012 Q3 | -0.10 EUR | 0.0% |
| 2012 FY | - EUR | 16.28% |
| 2012 Q1 | -0.10 EUR | 0.0% |
| 2012 Q2 | -0.10 EUR | 0.0% |
| 2012 Q4 | -0.29 EUR | -190.0% |
| 2011 Q2 | -0.12 EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q1 | -0.12 EUR | 0.0% |
| 2011 Q4 | -0.10 EUR | 16.67% |
| 2011 Q3 | -0.12 EUR | 0.0% |
| 2010 Q4 | -0.12 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -658.333% |
| ABIVAX Société Anonyme | -3.43 EUR | 73.469% |
| Adocia SA | -1.91 EUR | 52.356% |
| Aelis Farma SA | -0.39 EUR | -133.333% |
| Biophytis S.A. | -12.55 EUR | 92.749% |
| Advicenne S.A. | -0.67 EUR | -35.821% |
| genOway Société anonyme | 0.17 EUR | 635.294% |
| IntegraGen SA | -0.03 EUR | -3413.514% |
| Medesis Pharma S.A. | -0.80 EUR | -13.75% |
| Neovacs S.A. | -0.00 EUR | -36300.0% |
| NFL Biosciences SA | -0.46 EUR | -97.826% |
| Plant Advanced Technologies SA | 0.07 EUR | 1400.0% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -900.0% |
| Sensorion SA | -0.17 EUR | -435.294% |
| Theranexus Société Anonyme | -0.88 EUR | -3.409% |
| TME Pharma N.V. | -1.34 EUR | 32.09% |
| Valbiotis SA | -0.59 EUR | -54.237% |
| TheraVet SA | -0.49 EUR | -85.714% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -506.667% |
| DBV Technologies S.A. | -0.71 EUR | -28.169% |
| Genfit S.A. | -0.58 EUR | -56.897% |
| GeNeuro SA | -0.59 EUR | -54.237% |
| Innate Pharma S.A. | -0.09 EUR | -867.056% |
| Inventiva S.A. | -2.43 EUR | 62.551% |
| MaaT Pharma SA | -1.73 EUR | 47.399% |
| MedinCell S.A. | -0.88 EUR | -3.409% |
| Nanobiotix S.A. | -1.08 EUR | 15.741% |
| OSE Immunotherapeutics SA | -1.18 EUR | 22.881% |
| GenSight Biologics S.A. | -0.54 EUR | -68.519% |
| Transgene SA | -0.22 EUR | -313.636% |
| Valneva SE | -0.73 EUR | -24.658% |